The chief financial officer of Wyeth expressed optimism on February 9th that tens of thousands of lawsuits by users of the recalled "fen-phen" diet drugs may be settled during the next year or two.

Pondimin (fenfluramine hydrochloride) and Redux (dexfenfluramine), the two drugs that made up the "fen" portion of what in the 1990s was the extraordinarily popular fen-phen diet drug combination, were pulled from the market on September 15, 1997.

Redux and Pondimin, when used in combination with phentermine (which remains on the market), allegedly caused heart-valve problems, primary pulmonary hypertension, and in some cases neurotoxic brain injury.

Read more about Wyeth's intention to settle its Fen-phen lawsuits at http://www.dietdrugreport.com/News/news-020906.htm.